en · de · es · fr · pt
glossary-desk.peptides9002.com › Blog › Background And Peptide Identity — Questions and Answers

Background And Peptide Identity — Questions and Answers

By Editorial Desk · published 2025-09-03 · last reviewed 2025-10-12 · Blog

The short version of Certificate of analysis fits in a sentence. The long version — which is the one that helps — is below.

Reviewed 2025-10-12. Anything still debated is marked as such rather than presented as settled.

Background and Peptide Identity

Tuftsin, the parent structure, is a naturally occurring immunomodulatory tetrapeptide released from the Fc region of immunoglobulin G by spleen enzymes. Selank extends this four-residue sequence with three additional amino acids. The stated rationale is that the added tail slows enzymatic breakdown and may influence receptor interactions. How the full heptapeptide behaves at the molecular level is not firmly established, and proposed mechanisms often involve indirect modulation of neurotransmitter or immune signaling rather than a single defined target.

Selank is a synthetic heptapeptide developed in Russia. Its sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, a seven-residue chain built around the natural tetrapeptide tuftsin. Researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences first described the compound in the mid-1990s. The design combined the tuftsin core with an added Pro-Gly-Pro tail, a modification intended to extend the molecule's stability in biological fluids. Published work on the peptide has appeared mainly in Russian-language journals.

Reported activity for Selank centers on anxiolytic and nootropic effects. Russian clinical reports describe use in anxiety and in cognitive or attention-related complaints. Most of this evidence comes from studies conducted by the same research groups that developed the peptide. Independent replication in other countries remains limited, and no major Western regulatory agency has approved the compound for any indication. The gap between local reports and external verification is a recurring point in discussions of the peptide.

Peptide Identity and Structure

The compound was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences during the 1980s and 1990s. The stated design goal was to retain the immunomodulatory and central nervous system activity attributed to tuftsin while improving resistance to enzymatic breakdown. Adding a proline-rich tail to the short parent peptide was a deliberate strategy, because proline residues restrict the conformations available to many peptidases. The same laboratory produced Semax, an ACTH fragment analog, and both compounds were developed in parallel as short, enzymatically stabilized peptides intended for intranasal use.

Selank is not a naturally occurring peptide and has no known endogenous counterpart in human physiology. Russian-language sources frequently call it TP-7, while English-language sources use the name Selank almost exclusively. Database indexing is uneven, partly because early reports appeared in regional journals that are not widely cataloged. Some summaries describe the material as a tuftsin analog and others as a synthetic heptapeptide; the labels overlap rather than conflict. Citing the primary sequence resolves ambiguity more reliably than the research or trade name alone.

Selank at a glance

PropertyValueNotes
Chemical classSynthetic heptapeptideModeled on tuftsin
Amino acid sequenceThr-Lys-Pro-Arg-Pro-Gly-ProSeven residues
Approximate molecular massAround 750 DaDepends on counter-ion and hydration
Common formsLyophilized powderAlso described as aqueous solution
Primary origin of researchRussian laboratoriesMid-1990s onward

Selank Background And Chemical Identity

Selank is a synthetic heptapeptide developed in Russia during the 1990s. Researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences designed it as a stabilized analog of tuftsin, a naturally occurring immunomodulatory tetrapeptide. The compound has been studied primarily for its reported anxiolytic and nootropic effects. It remains largely unknown in Western pharmacology and is not approved as a medicine by major regulators such as the FDA or the EMA.

The primary structure of Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro, corresponding to the molecular formula C33H57N11O9 and a monoisotopic mass of roughly 751.9 daltons. The N-terminal threonine and the arginine residue in the fourth position are shared with tuftsin, which carries the sequence Thr-Lys-Pro-Arg. The three additional residues at the C-terminus, Pro-Gly-Pro, extend the chain and are associated with greater resistance to enzymatic degradation. This extension also separates Selank from the shorter parent peptide.

Related pages on this site

Storage, Analysis, and Regulatory Status

Dry powder is normally held at -20 degrees Celsius or lower, in a sealed container with desiccant and protection from light. Reconstituted solutions are usually kept at 2 to 8 degrees Celsius for short periods and frozen for longer ones. Proline residues at several positions are generally associated with some resistance to peptidase attack, but chemical stability still declines at neutral to alkaline pH and at elevated temperature. Exact shelf-life figures are product-specific and are not standardised across suppliers.

Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, with mass spectrometry used to confirm molecular mass and sequence information. Amino acid analysis and peptide mapping may supplement these methods. Certified reference standards are scarce, and many commercial lots are sold as research chemicals without a pharmacopoeial monograph. Regulatory treatment differs by country: Selank is a registered prescription medicine in Russia, while in the European Union and the United States it is not an approved drug and may fall under research-chemical or unapproved-product frameworks.

Selank is a hydrophilic peptide and dissolves readily in water and in aqueous buffers. The lyophilised powder is typically a white to off-white solid. Because short peptides are prone to hydrolysis and oxidation, handling benefits from limiting exposure to heat, moisture and strong light. Working solutions are commonly prepared in sterile water or saline, and repeated freeze-thaw cycles are avoided to reduce aggregation and loss of activity. These practices reflect general laboratory convention rather than published stability specifications.

Notes from published material

== Cast == Ruby Lin as Gu Manzhen (顧曼楨) Patrick Tam as Shen Shijun (沈世鈞) Jiang Qinqin as Gu Manlu (顧曼璐) Li Li-chun as Zhu Hongcai (祝鴻才) Hu Ke as Shi Cuizhi (石翠芝) Chang Chang as Xu Shuhui (許叔惠) Xing Minshan as Zhang Yujin (張豫瑾)

== Side effects == The most common side effect in all insulin analogues is low blood sugar, while in more serious cases, side effects may include low blood potassium. Insulin allergies are also a concern, although they are not prevalent, affecting only about 2% of people in some form. Insulin analogues are generally considered safe during pregnancy, and many are used in the treatment of gestational diabetes.

=== Low BMD === Bone Mineral Density (BMD) tends to peak at a young age. When children are younger, they start building up their BMD through their nutrition and through exercise. BMD peaks at around 12.5 years old for girls and around 14 years old for boys. It could be caused by a deficiency in calcium or Vitamin D. Calcium is the main nutrient for bone health. It aids in the structure and density of the bone. Low BMD could be caused by the children not getting the proper exercise for adequate bone growth. Researchers suggest that children should get 20 minutes of vigorous activity 3 to 5 days a week to promote an increase in BMD. Jumping for about 5 minutes a day also stimulates an increase in BMD. Researchers did a 10-year study on the effects of vigorous intensity activity and their bone health/strength. They studied 300 boys and girls. They found that in boys going through puberty (ages 11-13), they experienced a greater bone mass growth. Their bone mass increased during this time because their bones are not ready for the mechanical stress from them growing. However, that is how the bones grow stronger and why their BMD increases. Too much stress on the bones could cause BMD to decrease. Low BMD is dangerous because it can cause disorders inside the bone as the children grow and get older. These disorders can cause the bone to ossify, become brittle, fragile, more easily prone to fractures, and weak. Some of these disorders include osteopenia, osteoporosis, and scoliosis. Scoliosis is very common in children. Low BMD plays a role in the child's scoliosis.

Colonel Mukaiyama – reportedly a staff officer in the 38th Army, who became a technical advisor to the Vietnamese. Credited as the leader of Japanese forces in Vietnam; killed in combat in 1946. Colonel Masanobu Tsuji – Operations Staff Officer. Major Ishii Takuo – a staff officer in the 55th Division who had commanded a squadron of its cavalry regiment. Supposedly the youngest major in the Imperial Army at the time, he led a number of volunteers to the Vietnamese cause, becoming a colonel and military advisor to General Nguyễn Sơn. He headed the Quảng Ngãi Military Academy for a while before founding the Tuy Hòa Military Academy, and was killed by a land mine in 1950. Major Kanetoshi Toshihide – served with Major Igari in the 2nd Division and followed him to join the Việt Minh; he became Chief of Staff for General Nguyễn Giác Ngộ. Major Igawa Sei – a staff officer in the 34th Independent Mixed Brigade; he joined the Viet Minh forces, and was killed in action against the French in 1946. He allegedly conceived the idea of establishing the Quảng Ngãi Military Academy. Lieutenant Igari Kazumasa – the commander of an infantry company in the 2nd Division's 29th Infantry Regiment; he became an instructor at the Quảng Ngãi Military Academy. Lieutenant Kamo Tokuji – a platoon leader under Lieutenant Igari; he also became an instructor at the Quảng Ngãi Military Academy.

Sources: en.wikipedia.org

Further detail

== Selected publications == Zubarev, R. A.; Kelleher, N. L.; McLafferty, F. W. (1998). "Electron Capture Dissociation of Multiply Charged Protein Cations. A Non-ergodic Process". Journal of the American Chemical Society. 120 (13): 3265–3266. Bibcode:1998JAChS.120.3265Z. doi:10.1021/ja973478k. Xie, X.; Zubarev, R. A. (2015). "Isotopic resonance hypothesis: experimental verification by Escherichia coli growth measurements". Scientific Reports. 5 9215: 9210. arXiv:1407.4847. Bibcode:2015NatSR...5.9215X. doi:10.1038/srep09215. PMID 25782666. Yang, H.; Lyutvinskiy, Y.; Herukka, S.-K.; Soininen, H.; Rutishauser, D.; Zubarev, R. A. (2014). "Prognostic polypeptide blood plasma biomarkers of Alzheimer's disease progression". Journal of Alzheimer's Disease. 40 (3): 659–666. doi:10.3233/JAD-132102. PMID 24503613. Xie, X.; Backman, D.; Lebedev, A. T.; Artaev, V. B.; Jiang, L.; Ilag, L. L.; Zubarev, R. A. (2015). "Primordial soup was edible: abiotically produced Miller–Urey mixture supports bacterial growth". Scientific Reports. 5 14338. Bibcode:2015NatSR...514338X. doi:10.1038/srep14338. PMC 4585927. PMID 26412575.

On November 16, 2004, Valve released Half-Life 2. The game had a six-year development cycle, which saw several delays and the leak of the game's source code in October, 2003. Half-Life 2 returns the player to the role of Gordon Freeman. Set twenty years after the original game, Earth has been occupied by the Combine, a transdimensional race that exploited the events of the first game to invade. The G-Man inserts Freeman into City 17 in Eastern Europe to combat the Combine occupation. Considered one of the greatest video games of all time, Half-Life 2 was praised for its advances in computer animation, sound, narration, computer graphics, artificial intelligence and physics, and won more than 35 Game of the Year awards. Half-Life 2 was the first game to use Valve's Steam content delivery system, a system that eventually led to Valve falling out with publisher Sierra Entertainment.

The hypothalamus uses thyrotropin-releasing hormone (TRH or thyroliberin) to tell the pituitary to release thyrotropin. The hypothalamus uses corticotropin-releasing hormone (CRH or corticoliberin) to tell the pituitary to release corticotropin. The hypothalamus uses gonadotropin-releasing hormone (GnRH or gonadoliberin) to tell the pituitary to release gonadotropin. The hypothalamus uses growth hormone–releasing hormone (GHRH or somatoliberin) to tell the pituitary to release somatotropin. The main release-inhibiting hormones or inhibiting hormones are as follows:

Sources: en.wikipedia.org

Background from the literature

=== Terrestrial === The composition of terrestrial species on the Kuril islands is dominated by Asian mainland taxa via migration from Hokkaido and Sakhalin Islands and by Kamchatkan taxa from the North. While highly diverse, there is a relatively low level of endemism on a species level. The WWF divides the Kuril Islands into two ecoregions. The southern Kurils, along with southwestern Sakhalin, comprise the South Sakhalin-Kurile mixed forests ecoregion. The northern islands are part of the Kamchatka-Kurile meadows and sparse forests, a larger ecoregion that extends onto the Kamchatka Peninsula and Commander Islands. The Miyabe Line dividing the differing sets of predominant plants of the Kurils corresponds to the Vries Strait between Iturup and Urup. Because of the generally smaller size and isolation of the central islands, few major terrestrial mammals have colonized these, though red and Arctic foxes were introduced for the sake of the fur trade in the 1880s. The bulk of the terrestrial mammal biomass is taken up by rodents, many introduced in historical times. The largest southernmost and northernmost islands are inhabited by brown bear, foxes, and martens. Leopards once inhabited the islands. Some species of deer are found on the more southerly islands. It is claimed that a wild cat, the Kurilian Bobtail, originates from the Kuril Islands. The bobtail is due to the mutation of a dominant gene. The cat has been domesticated and exported to nearby Russia and bred there, becoming a popular domestic cat.

AM function can be compared to another peptide called pro-adrenomedullin N-terminal 20 peptide (PAMP), which both originate from a common precursor leading to angiogenesis, vasodilation, and anti-inflammatory processes. These two peptides are expressed in the gastrointestinal (GI) tract at a mass level, serving as GI hormones controlling processes like insulin secretion and gastric emptying. Past studies reveal that AM and PAMP also impact gut microbiome composition by fostering the development of beneficial bacteria (i.e., Bifidobacterium and Lactobacillus) and diminishing detrimental microbes.

== Health and death == When Todd signed on to film Final Destination Bloodlines in 2023, he privately let the producers know that he had terminal stomach cancer. During filming in early 2024, they elected to allow Todd to improvise the last lines of his character Mr. Bludworth so he could give a proper goodbye to audiences: "Life is precious, enjoy every single second. You never know when ... Good luck". Todd died at his home in Marina del Rey, California, on November 6, 2024, at the age of 69. His cause of death was listed as stomach cancer. Both Final Destination Bloodlines and Indiana Jones and the Great Circle were dedicated to his memory. Insomniac Games intended to make a spin-off video game starring Venom after Todd played the character in Marvel's Spider-Man 2. However, the game was reportedly cancelled or placed on the backburner after his death. Both his co-stars Nadji Jeter (whom Todd affectionally called "nephew") and Yuri Lowenthal attended his funeral.

The dative anchoring strategy uses natural amino acid residue in the protein scaffold like His, Cys, Glu, Asp and Ser to coordinate to a metal center. Like the first example of Pd-fibroin, dative anchoring to natural amino acids is not commonly used nowadays and often resulted in a more ambiguous binding site for metal compared with previous three methods. However, these challenges can be overcome by in vivo incorporating metal-chelating non-canonical amino acids (ncAAs) in the protein scaffold. These genetically encoded ncAAs' side chains have chelating moieties, such as 2,2'-bipyridine (3-(2,2'-bipyridin-5-yl)-L-alanine) and 8-hydroxyquinoline (2-amino-3-(8-hydroxyquinolin-3-yl)propanoic acid) that can selectively coordinate different metals. Combining protein scaffolds featuring chelating ncAAs with different metals yields exceptionally selective artificial metalloenzymes with various application potentials. ncAAs are usually incorporated through the means of Amber stop codon suppression, via the orthogonal translation system (OTS). Metal-chelating non-canonical amino acids can also be introduced to a protein scaffold in vitro, for example by covalently linking a bromine-substituted picolines to native cysteine residues. The cysteine-sulphur substitutes the bromine, forming a picoline-substituted cysteine which in turn can coordinate a metallocofactor.

Sources: en.wikipedia.org

Frequently asked questions

What type of molecule is Selank?

Selank is a synthetic peptide made of seven amino acids. It is modeled on tuftsin, a natural tetrapeptide, with an added three-residue tail. It is not a small-molecule drug.

Where was Selank developed?

It originates from research in Russia, associated with the Institute of Molecular Genetics of the Russian Academy of Sciences. The first descriptions date to the mid-1990s. Most published studies come from Russian laboratories.

Is Selank found in nature?

No, Selank itself does not occur naturally. Its backbone is based on tuftsin, which is produced in the body, but the seven-residue version is a synthetic construct. It is supplied as a manufactured peptide.

What is the primary sequence of Selank?

The sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, written TKPRPGP in one-letter code. It combines the tetrapeptide tuftsin with a carboxyl-terminal Pro-Gly-Pro extension. This full sequence identifies the molecule more precisely than the research name.

Network